ICICI Prudential directed by NCDRC to pay Rs 5L to policy holder for denying claim

Image
Press Trust of India New Delhi
Last Updated : Jun 17 2019 | 8:40 PM IST

Apex consumer forum NCDRC has directed ICICI Prudential Life Insurance Co Ltd to pay over Rs 5 lakh to a Maharashtra resident for providing deficient services by repudiating his claim for reimbursement of medical expenses on the ground that he had not disclosed a pre-existing disease.

The National Consumer Disputes Redressal Commission (NCDRC) observed that ICICI Prudential had obtained and used a "suspicious medical certificate" for denying the claim.

"It is an unfair and deceptive act and amounts to unfair trade practice", the commission said and directed the company to pay Dattatrey Bhivsan Gujar 75 per cent of his claimed amount, that is Rs 4,15,030, along with Rs 1 lakh for mental, financial and physical hardship.

The NCDRC directed that the amount be paid within four weeks from June 14.

Gujar had in 2008 taken an insurance policy named ICICI-Pru Hospital Care.

He had no illness from 2008 to August 2012. On September 18, 2012, he was admitted in Bombay Hospital due to abdominal pain and was diagnosed with renal (kidney) ailments.

Gujar, who underwent dialysis, and subsequently a kidney transplant, approached the insurance company for reimbursement of hospitalisation expenses, which was repudiated on the ground of "non-disclosure of pre-existing medical condition".

The insurance company repudiated his claim by relying principally on a certificate issued by one Dr Rajendra G Chandorkar which stated that Gujar was a known patient of diabetes and hypertension for the last 10 years.

The commission noted that Dr Chandorkar was a pediatrician, and not a a physician, or an endocrinologist, to certify a person as diabetic and hypertensive.

"Nothing is on record that the said Dr Chandorkar has either examined or treated the complainant for diabetes or hypertension in the past 10 years. Ex facie, a suspicious medical certificate was issued. It is not viewed favourably," Commission's Presiding member S M Kantikar and member Dinesh Singh said.

"We would not like to turn a blind eye on the issuance of the ex facie suspicious medical certificate by the said Chandorkar to unduly help the insurance company in taking its principal ground for repudiation of the insurance claim. Issuance of such medical certificate is unethical and amounts to professional misconduct, which needs suitable action from the concerned professional regulatory body," the commission said.

It directed registrar of the commission to refer the matter to Maharashtra Medical Council, Mumbai, for appropriate action against Dr Chandorkar, according to the rules.

Gujar had moved the district forum which had passed an order in his favour on October 31, 2015.

The insurance company's petition challenging the lower fora's order was rejected by Maharashtra state commission, after which ICICI Prudential moved the NCDRC for review of the order.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 17 2019 | 8:40 PM IST

Next Story